Fluidigm Corporation (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. purchased 6,880 shares of the company’s stock in a transaction on Friday, November 17th. The stock was acquired at an average price of $5.05 per share, for a total transaction of $34,744.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Wednesday, November 8th, Levin Capital Strategies, L.P. purchased 54,900 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $5.26 per share, for a total transaction of $288,774.00.
  • On Wednesday, October 25th, Levin Capital Strategies, L.P. purchased 4,227 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $5.42 per share, for a total transaction of $22,910.34.
  • On Monday, October 23rd, Levin Capital Strategies, L.P. purchased 22,363 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $5.47 per share, for a total transaction of $122,325.61.
  • On Thursday, October 19th, Levin Capital Strategies, L.P. purchased 60,000 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $4.55 per share, for a total transaction of $273,000.00.
  • On Tuesday, October 17th, Levin Capital Strategies, L.P. purchased 144,200 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $4.59 per share, for a total transaction of $661,878.00.
  • On Monday, October 9th, Levin Capital Strategies, L.P. purchased 50,000 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $4.59 per share, for a total transaction of $229,500.00.
  • On Tuesday, October 10th, Levin Capital Strategies, L.P. purchased 95,843 shares of Fluidigm Corporation stock. The stock was bought at an average cost of $4.57 per share, for a total transaction of $438,002.51.
  • On Tuesday, September 12th, Levin Capital Strategies, L.P. purchased 60,000 shares of Fluidigm Corporation stock. The stock was bought at an average cost of $5.25 per share, for a total transaction of $315,000.00.

Shares of Fluidigm Corporation (NASDAQ:FLDM) traded up $0.23 on Friday, reaching $5.60. The company had a trading volume of 238,300 shares, compared to its average volume of 258,754. Fluidigm Corporation has a 1 year low of $2.52 and a 1 year high of $8.69. The company has a debt-to-equity ratio of 5.00, a quick ratio of 2.46 and a current ratio of 3.02.

ILLEGAL ACTIVITY WARNING: This report was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/fluidigm-corporation-fldm-insider-purchases-34744-00-in-stock/1724395.html.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Wells Fargo & Company MN grew its stake in Fluidigm Corporation by 15.0% during the 1st quarter. Wells Fargo & Company MN now owns 25,521 shares of the medical research company’s stock valued at $146,000 after acquiring an additional 3,327 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Fluidigm Corporation by 20.5% during the 1st quarter. Bank of New York Mellon Corp now owns 206,578 shares of the medical research company’s stock valued at $1,175,000 after acquiring an additional 35,176 shares in the last quarter. American International Group Inc. grew its stake in Fluidigm Corporation by 7.1% during the 1st quarter. American International Group Inc. now owns 17,907 shares of the medical research company’s stock valued at $102,000 after acquiring an additional 1,187 shares in the last quarter. Vanguard Group Inc. grew its stake in Fluidigm Corporation by 1.7% during the 1st quarter. Vanguard Group Inc. now owns 1,181,883 shares of the medical research company’s stock valued at $6,725,000 after acquiring an additional 19,669 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in Fluidigm Corporation by 1.5% during the 1st quarter. Geode Capital Management LLC now owns 218,321 shares of the medical research company’s stock valued at $1,242,000 after acquiring an additional 3,311 shares in the last quarter. 78.65% of the stock is currently owned by hedge funds and other institutional investors.

Separately, ValuEngine cut Fluidigm Corporation from a “sell” rating to a “strong sell” rating in a research note on Thursday, November 9th.

Fluidigm Corporation Company Profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm Corporation (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.